FierceMedicalDevices
  • FierceBiotech
  • FierceBiotechIT
  • FierceBiotechResearch
  • FierceBiomarkers
  • FierceDrugDelivery
  • FierceMedicalDevices
  • FierceVaccines
  • FiercePharma
  • FiercePharmaManufacturing
  • FierceCRO
  • More Fierce Network sites
  • Select another site
  • Advertise
  • Contact

Free Daily Medical Devices Newsletter Stay up-to-speed on the medical device and diagnostic industry with a daily update sent straight to your Inbox. Join fellow executives, device developers, engineers, and researchers who subscribe to FierceMedicalDevices for FREE! Click here to see a sample.

FierceMedicalDevices

  • News
  • TOPICS
    • Companion Diagnostics
    • Device Safety
    • Device Studies
    • Diagnostics
    • Emerging Markets
    • Europe
    • M&A
    • Outsourcing
    • Partnering
    • R&D
    • Recalls
    • Regulatory
    • Social Media
  • ANALYSIS
    • FierceMedicalDevices sports a new look
      by Liz Hollis
    • We're looking for the 15 fiercest device developers
      by Arsalan Arif
    • More commentary
  • FEATURES
    • Top 10 Medical Device R&D Budgets
    • Top 10 VC medical device deals H2 2011
    • 5 Innovative Michigan companies
  • LIBRARY
    • Webinars
    • View All
  • EVENTS
  • JOBS
    • Browse Jobs
    • Post a Job
  • Marketplace
  • Susbscribe
  • Twitter
  • Mobile
Follow US
Tag:

Gambro

Latest Headlines

Latest Headlines

Two liver dialysis machines don't extend lives

April 16, 2010
Two liver dialysis machines made by Fresenius Medical Care and Gambro don't extend the lives of patients with liver failure, according to studies presented at the International Liver Congress in

Related Tags

  • Fresenius Medical Care
  • Baxter International
  • Liver dialysis
  • medical device market

Gambro Press Releases

  • Research and Markets: Nephrology and Urology Devices Market Outlook in Austria to 2017 - Incontinence Devices, Renal Dialy
  • Research and Markets: Nephrology and Urology Devices Market Outlook in France to 2017 - Incontinence Devices, Renal Dialys
  • Research and Markets: Ireland Nephrology and Urology Devices Investment Opportunities, Analysis and Forecasts to 2017
  • Research and Markets: Portugal Nephrology and Urology Devices Investment Opportunities, Analysis and Forecasts to 2017
  • Research and Markets: Chile Nephrology and Urology Devices Investment Opportunities, Analysis and Forecasts to 2017

Join 31,000+ Insiders SIGN UP FOR OUR NEWSLETTER

THE LIBRARY: WEBINAR

Getting the most PoC data in Phase I cancer studies

| June 12, 11am ET/ 8am PT

The hunt for proof-of-concept data is steadily moving upstream in the clinic. Join FierceBiotech on June 12th as three clinical trial experts tackle the question of how you can best design a Phase I study to get a readout on efficacy. Topics will include: enrollment, dosing and the best possible use of biomarkers for experimental cancer drugs. Register Today!

MORE ITEMS

EVENTS

  • MDMA Annual Meeting May 30th - June 1st, 2012 — Washington, DC
  • HTA in Medtech - Free SymposiumSaturday, June 2, 2012 — ISPOR Washington
  • Clinical Trials Eastern Europe Webinar SeriesMay 15-June 12 — Eastern Europe
MORE EVENTS

Press Releases

  • New York Genome Center Announces Formal Commencement of Collaborative Relationship with Illumina
  • Baxano Completes Enrollment in Lumbar Spinal Stenosis Study
  • PRA Expands Operations in Europe
  • New Study Details Foreign Efforts To Lure Biopharmaceutical Companies
  • Greatbatch to Establish New Global Headquarters
  • More Press Releases

Featured Jobs

  • Pharmacist (Drug Safety and Product Information) Job
    Yoh - Durham, NC, USA
  • Statistician Job
    Yoh - Montville, NJ, USA
  • Microbiology Scientist
    C3 Jian - Marina Del Rey, CA
  • Biostatistician (Entry Level) - Permanent Job
    Yoh - Tarrytown, NY, USA
  • Director, Safety Pharmacology and Toxicology
    Tesaro - Waltham, MA

A publication of FierceMarkets

FierceMedicalDevices provides breaking news and critical insights into the medical device and diagnostics industries, with a special emphasis on clinical studies, FDA/EMEA regulations, and post-marketing. Click here to get your free weekly email briefing today!

The FierceMarkets Network:

Telecom
  • FierceWireless
  • FierceBroadbandWireless
  • FierceMobileContent
  • FierceDeveloper
  • FierceWireless:Europe
  • FierceTelecom
  • FierceEnterpriseCommunications
  • FierceIPTV
  • FierceOnlineVideo
  • FierceCable
Healthcare
  • FierceHealthcare
  • FiercePracticeManagement
  • FierceHealthIT
  • FierceHealthFinance
  • Hospital Impact
  • FierceEMR
  • FierceMobileHealthcare
  • FierceHealthPayer
Government
  • FierceGovernment
  • FierceGovernmentIT
  • FierceHomelandSecurity
Energy
  • FierceEnergy
  • FierceSmartGrid
Life Sciences
  • FierceBiotech
  • FierceBiotechResearch
  • FiercePharma
  • FierceVaccines
  • FierceBiotechIT
  • FiercePharmaManufacturing
  • FierceMedicalDevices
  • FierceDrugDelivery
  • FierceBiomarkers
  • FierceCRO
Enterprise IT
  • FierceCIO
  • FierceCIO:TechWatch
  • FierceMobileIT
  • FierceContentManagement
Finance
  • FierceFinance
  • FierceComplianceIT
  • FierceFinanceIT
  • Home
  • Subscribe
  • Advertise
  • Mobile Edition
  • RSS
  • Privacy
  • Editors
© 2012 FierceMarkets. All rights reserved.